SHANE COURTNEY: Open Payments
NPI 1528491719 · LINWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,343 in 166 payments from 17 companies in 2025. Trend: 2023 $2,319 · 2024 $2,659 · 2025 $2,343
Food & beverage: $2,222Education: $121
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $407 |
| UCB, Inc. | 25 | $342 |
| Novartis Pharmaceuticals Corporation | 15 | $184 |
| Incyte Corporation | 9 | $170 |
| Botanix SB Inc | 11 | $161 |
| Janssen Biotech, Inc. | 4 | $152 |
| PFIZER INC. | 11 | $148 |
| Organon LLC | 19 | $145 |
| Regeneron Healthcare Solutions, Inc. | 9 | $142 |
| Amgen Inc. | 7 | $117 |
Products named: Bimzelx, RINVOQ, SKYRIZI, OPZELURA, DUPIXENT, SOFDRA, TREMFYA, CIBINQO.
Industry payments across NJ — which companies pay providers there.
